OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Cachexia Sarcopenia and Muscle is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis	548
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021	335
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults	232
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review	209
Understanding the gut microbiota and sarcopenia: a systematic review	161
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19	138
Effects of statins on mitochondrial pathways	124
The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.	112
Mouse models of sarcopenia: classification and evaluation	109
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis	103
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study	97
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers	95
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality	92
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults	88
Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS	87
Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis	86
Gut microbes and muscle function: can probiotics make our muscles stronger?	83
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting	82
Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy	81
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis	79
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients	77
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China	74
Roles of nutrition in muscle health of community‐dwelling older adults: evidence‐based expert consensus from Asian Working Group for Sarcopenia	73
Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review	70
Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis	70

Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women	69
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study	69
Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle	67
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial	65
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis	64
Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study	64
How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review	61
Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project	58
ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke	58
Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 mice	57
Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia	57
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)	56
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis	55
Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7	53
Age‐related alterations in muscle architecture are a signature of sarcopenia: the ultrasound sarcopenia index	53
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies	52
The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review	52
Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a	51
Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis	51
Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study	50
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia	49
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle	49
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer	48
Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry	48
TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration	47
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models	47
A systematic review examining the relationship between cytokines and cachexia in incurable cancer	46
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome	45
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand	45
Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the Hertfordshire Cohort Study	44
The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis	44
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction	44
Prognostic impact of muscle and fat mass in patients with heart failure	43
Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study	43
Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis	43
Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults	42
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer	42
Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: A systematic review and meta‐analysis	42
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)	41
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia	41
Relative sit‐to‐stand power: aging trajectories, functionally relevant cut‐off points, and normative data in a large European cohort	41
Incidence of cardiovascular disease and mortality in underweight individuals	40
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study	40
Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire	40
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin	40
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes	39
Higher dietary fibre intake is associated with increased skeletal muscle mass and strength in adults aged 40 years and older	39
Severe loss of mechanical efficiency in COVID‐19 patients	39
Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial	39
Predicted fat mass and lean mass in relation to all‐cause and cause‐specific mortality	38

Effects of β‐hydroxy β‐methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review	38
Activation of Akt–mTORC1 signalling reverts cancer‐dependent muscle wasting	38
Mitochondrial dysfunction in skeletal muscle contributes to the development of acute insulin resistance in mice	38
Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset	38
Role of sarcopenia in the frailty transitions in older adults: a population‐based cohort study	37
Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta‐analysis	37
circRNAome profiling reveals circFgfr2 regulates myogenesis and muscle regeneration via a feedback loop	36
Female mice may have exacerbated catabolic signalling response compared to male mice during development and progression of disuse atrophy	36
Decoding the transcriptome of denervated muscle at single‐nucleus resolution	36
Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of	36
Population‐based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study	36
Red meat consumption and risk of frailty in older women	36
AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology	36
Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo‐controlled D‐Health Trial	35
Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review	35
Handgrip strength asymmetry is associated with the risk of neurodegenerative disorders among Chinese older adults	35
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research	35
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications	35
Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study	34
Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice	34
Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants	34
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice	34
Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis	34
Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study	34
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma	34
Autophagy in muscle regeneration: potential therapies for myopathies	34
Twelve‐year sarcopenia trajectories in older adults: results from a population‐based study	34
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?	34
Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study	33
Ribosome biogenesis and degradation regulate translational capacity during muscle disuse and reloading	33
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis	33
A systematic review and meta‐analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia	33
Muscle strength is associated with COVID‐19 hospitalization in adults 50 years of age or older	33
Total and regional fat‐to‐muscle mass ratio measured by bioelectrical impedance and risk of incident type 2 diabetes	32
Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease	32
Declines in muscle protein synthesis account for short‐term muscle disuse atrophy in humans in the absence of increased muscle protein breakdown	32
Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study	32
The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men	32
Absolute and relative grip strength as predictors of cancer: prospective cohort study of 445 552 participants in UK Biobank	31
Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy	31
Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control	30
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma	30
Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial	30
Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia	30
Sarcopenia as potential biological substrate of long COVID‐19 syndrome: prevalence, clinical features, and risk factors	30
Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity	30
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation	30
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia	29
Inflammation‐induced cholestasis in cancer cachexia	29
The time course of disuse muscle atrophy of the lower limb in health and disease	29
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey	29
ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia	28
Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators	28
Impact of high‐intensity interval training with or without l‐citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults	28
Impact of probiotics on muscle mass, muscle strength and lean mass: a systematic review and meta‐analysis of randomized controlled trials	28
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy	27
Associations between frailty trajectories and frailty status and adverse outcomes in community‐dwelling older adults	27
Muscle density is an independent risk factor of second hip fracture: a prospective cohort study	27
Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study	27
Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease	27
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies	27
Protein intake and risk of frailty among older women in the Nurses' Health Study	27
The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project	26
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients	26
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility	26
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)	26
Differences in the mass and quality of the quadriceps with age and sex and their relationships with knee extension strength	26
Intramuscular adipose tissue in the quadriceps is more strongly related to recovery of activities of daily living than muscle mass in older inpatients	25
Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular disease	25
Mitochondria transplant therapy improves regeneration and restoration of injured skeletal muscle	25
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy	25
Effects of sarcopenia and malnutrition on morbidity and mortality in gynecologic cancer surgery: results of a prospective study	25
Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease	25
Muscle mass and estimates of renal function: a longitudinal cohort study	24
Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice	24
Sleep duration and progression to sarcopenia in Japanese community‐dwelling older adults: a 4 year longitudinal study	24
A randomized, feasibility trial of an exercise and nutrition‐based rehabilitation programme (ENeRgy) in people with cancer	24
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS	24
Weight‐adjusted waist as an integrated index for fat, muscle and bone health in adults	24
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial	24

Androgen receptor coordinates muscle metabolic and contractile functions	23
Loss of REDD1 prevents chemotherapy‐induced muscle atrophy and weakness in mice	23
Body composition reference ranges in community‐dwelling adults using dual‐energy X‐ray absorptiometry: the Australian Body Composition (ABC) Study	23
Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway	23
Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia	23
Prognostic significance of surgery‐induced sarcopenia in the survival of gastric cancer patients: a sex‐specific analysis	23
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop	23
The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients	23
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle	23
Vitamin D₃supplementation does not enhance the effects of resistance training in older adults	23
Association of anorexia/appetite loss with malnutrition and mortality in older populations: A systematic literature review	22
Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis	22
Mitochondrial aberrations during the progression of disuse atrophy differentially affect male and female mice	22
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy	22
The composition of the gut microbiome differs among community dwelling older people with good and poor appetite	22
The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab	22
Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study	22
Iron accumulation in skeletal muscles of old mice is associated with impaired regeneration after ischaemia–reperfusion damage	22
Is muscle and protein loss relevant in long‐term fasting in healthy men? A prospective trial on physiological adaptations	22
Association between the quality of plant‐based diets and risk of frailty	22
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice	22
Validating muscle mass cutoffs of four international sarcopenia‐working groups in Japanese people using DXA and BIA	22
Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice	22
Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults	22
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles	22
Recent sarcopenia definitions—prevalence, agreement and mortality associations among men: Findings from population‐based cohorts	22
Associations of metabolic heterogeneity of obesity with frailty progression: Results from two prospective cohorts	21
Transcriptomic meta‐analysis of disuse muscle atrophy vs. resistance exercise‐induced hypertrophy in young and older humans	21
The impact of senescence on muscle wasting in chronic kidney disease	21
Age‐specific and sex‐specific associations of visceral adipose tissue mass and fat‐to‐muscle mass ratio with risk of mortality	21
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps	21
Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice	21
Malnutrition outweighs the effect of the obesity paradox	21
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit	21
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles	21
Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index	21
The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle	21
Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study	21
The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review	20
Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models	20
Advanced cancer is also a heart failure syndrome: a hypothesis	20
Whole‐body and adipose tissue metabolic phenotype in cancer patients	20
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness	20
Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial	20
Amelioration of inflammatory myopathies by glucagon‐like peptide‐1 receptor agonist via suppressing muscle fibre necroptosis	20
Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia	20
Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study	20
Ten‐year longitudinal changes in muscle power, force, and velocity in young, middle‐aged, and older adults	19
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity	19
Sarcopenia as a prognostic indicator of liver cirrhosis	19
D₃‐creatine dilution for skeletal muscle mass measurement: historical development and current status	19
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience	19
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis	19
Frailty and heart failure: State‐of‐the‐art review	19
Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)	19
Sarcopenia and major complications in patients undergoing oncologic colon surgery	19
Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients	19
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy	18
The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer	18
Phenotypic differences between people varying in muscularity	18
Chronic aryl hydrocarbon receptor activity phenocopies smoking‐induced skeletal muscle impairment	18
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort	18
Sarcopenia and catastrophic health expenditure by socio‐economic groups in China: an analysis of household‐based panel data	18
Acute skeletal muscle loss in SARS‐CoV‐2 infection contributes to poor clinical outcomes in COVID‐19 patients	18
Body composition and osteoporotic fracture using anthropometric prediction equations to assess muscle and fat masses	18
Msi2‐mediated MiR7a‐1 processing repression promotes myogenesis	18
m⁶A demethylase ALKBH5 drives denervation‐induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling	18
Hypothalamic–pituitary–adrenal axis activation and glucocorticoid‐responsive gene expression in skeletal muscle and liver of Apc mice	18
Aging‐related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle	18
Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia	18
Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes	18
Ambra1 deficiency impairs mitophagy in skeletal muscle	17
Predictive validity of current sarcopenia definitions (EWGSOP2, SDOC, and AWGS2) for clinical outcomes: A scoping review	17
Association of shorter leucocyte telomere length with risk of frailty	17
The impact of sarcopenia on short‐term and long‐term mortality in patients with septic shock	17
Grip strength is inversely associated with DNA methylation age acceleration	17
C‐terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review	17
Body composition from single versus multi‐slice abdominal computed tomography: Concordance and associations with colorectal cancer survival	17
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis	17
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia	17
Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial	17
Chemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes	17
Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population	17
Gender differences in risk factors for the 2 year development of sarcopenia in community‐dwelling older adults	17
Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy	17
Computed tomography‐defined body composition as prognostic markers for unfavourable outcomes and in‐hospital mortality in coronavirus disease 2019	17
Atrophic skeletal muscle fibre‐derived small extracellular vesicle miR‐690 inhibits satellite cell differentiation during ageing	17
Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta‐analysis	17
Epigenome‐wide association study of sarcopenia: findings from the Hertfordshire Sarcopenia Study (HSS)	17
A randomized clinical trial on the effects of exercise on muscle remodelling following bariatric surgery	17
The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population	17
Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma	17
An umbrella review of systematic reviews of β‐hydroxy‐β‐methyl butyrate supplementation in ageing and clinical practice	17
MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review	16
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study	16